Answers are grounded in this paper and cite their sources.
The historical classification (1993) of anti-tuberculosis drugs included three (I-III) lines that were subdivided into five groups (2006). The duration of treatment of drug-sensitive (DS) tuberculosis (TB) with first-line drugs is 6 – 12 months; of multidrug-resistant (MDR) TB and extensively drug-resistant (XDR) TB with second-line drugs, 18 months and longer. The Directly Observed Treatment Short course (DOTS) and DOTS-Plus therapies are measures of world TB control. Based on the need for more effective treatment of MDR and XDR TB, the classification of 2016 introduced six groups (A-C and D1-D3) in connection with the development of new anti-TB drugs. The present review presents first-line preparations and their new derivatives possessing activity against DS and drug-resistant (DR) M. tuberculosis strains.
No takes yet. Share an insight, caveat, or question.
Kаyukova et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: